ID

29255

Description

Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01464099

Lien

https://clinicaltrials.gov/show/NCT01464099

Mots-clés

Versions (1)
  1. 12/03/2018 12/03/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

12 mars 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT01464099

Anglais

Eligibility Diabetes NCT01464099

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01464099
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with type 1 diabetes treated with insulin for at least 12 months
Description

Insulin-Dependent Diabetes Mellitus Disease length | Insulin regime

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
UMLS CUI [2]
C0557978
bmi (body mass index) between 18.0-29.0 kg/m^2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
negative fasting c-peptide (below or equal to 0.6 ng/ml)
Description

Fasting C-peptide level Negative

Type de données

boolean

Alias
UMLS CUI [1,1]
C2208720
UMLS CUI [1,2]
C1513916
hba1c (glycosylated haemoglobin a1c) below or equal to 10.0%
Description

Glucohemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
current treatment with insulin below or equal to 1.2 u/kg/day
Description

Insulin regime Unit/kilogram/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C1532634
subject should be in good health based on medical history, physical examination and routine laboratory data
Description

Good health Medical History | Good health Physical Examination | Good health Laboratory Results

Type de données

boolean

Alias
UMLS CUI [1,1]
C3813622
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C3813622
UMLS CUI [2,2]
C0031809
UMLS CUI [3,1]
C3813622
UMLS CUI [3,2]
C1254595
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any known/suspected allergies to trial medication or similar products/devices
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Similar | Hypersensitivity Suspected Pharmaceutical Preparations Similar | Hypersensitivity Investigational Medical Device Similar | Hypersensitivity Suspected Investigational Medical Device Similar

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C2348205
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C2348205
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C2346570
UMLS CUI [5,3]
C2348205
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0750491
UMLS CUI [6,3]
C2346570
UMLS CUI [6,4]
C2348205
a subject who has proliferative retinopathy or maculopathy, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
Description

Proliferative retinopathy | Disorder of macula of retina | Neuropathy Severe | Autonomic neuropathy

Type de données

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2]
C0730362
UMLS CUI [3,1]
C0442874
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0259749
clinically significant active disease of any kind
Description

Disease Clinical Significance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2826293
recurrent major hypoglycemia or hypoglycemic unawareness, as judged by the investigator
Description

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Type de données

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
blood donation (more than 500 ml) within the previous 9 weeks
Description

Blood Donation Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
Retour au début de la page

Similar models

Eligibility Diabetes NCT01464099

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01464099
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Insulin-Dependent Diabetes Mellitus Disease length | Insulin regime
Item
subjects with type 1 diabetes treated with insulin for at least 12 months
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0557978 (UMLS CUI [2])
Body mass index
Item
bmi (body mass index) between 18.0-29.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Fasting C-peptide level Negative
Item
negative fasting c-peptide (below or equal to 0.6 ng/ml)
boolean
C2208720 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hba1c (glycosylated haemoglobin a1c) below or equal to 10.0%
boolean
C0202054 (UMLS CUI [1])
Insulin regime Unit/kilogram/day
Item
current treatment with insulin below or equal to 1.2 u/kg/day
boolean
C0557978 (UMLS CUI [1,1])
C1532634 (UMLS CUI [1,2])
Good health Medical History | Good health Physical Examination | Good health Laboratory Results
Item
subject should be in good health based on medical history, physical examination and routine laboratory data
boolean
C3813622 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C3813622 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C3813622 (UMLS CUI [3,1])
C1254595 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Similar | Hypersensitivity Suspected Pharmaceutical Preparations Similar | Hypersensitivity Investigational Medical Device Similar | Hypersensitivity Suspected Investigational Medical Device Similar
Item
any known/suspected allergies to trial medication or similar products/devices
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C2348205 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C2348205 (UMLS CUI [4,4])
C0020517 (UMLS CUI [5,1])
C2346570 (UMLS CUI [5,2])
C2348205 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
C2346570 (UMLS CUI [6,3])
C2348205 (UMLS CUI [6,4])
Proliferative retinopathy | Disorder of macula of retina | Neuropathy Severe | Autonomic neuropathy
Item
a subject who has proliferative retinopathy or maculopathy, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
C0442874 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0259749 (UMLS CUI [4])
Disease Clinical Significance
Item
clinically significant active disease of any kind
boolean
C0012634 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycemia or hypoglycemic unawareness, as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Blood Donation Quantity
Item
blood donation (more than 500 ml) within the previous 9 weeks
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial